Flu season is here in the South Bend area, and other illnesses are in full swing as well. Here is what you need to know about the flu, the norovirus stomach bug, RSV and COVID. Influenza, or the flu, ...

Cases of RSV across the country are considered "very high," as rates of other acute respiratory illnesses are also high, the CDC reported Monday. Here's what to know about RSV. Iowa currently is ...

DURHAM, N.C. (WTVD) -- The CDC is warning of a rise in RSV cases in the Southeast in the offseason. Some children finding themselves sitting out portions of the summer because viruses are flaring up.

More severe symptoms of RSV include rapid breathing, difficulty breathing such as babies flaring their nostrils, ribs sucking ...

Respiratory syncytial virus (RSV) is a common respiratory virus which disproportionally affects new-borns and infants.

Flu season is here in New Jersey, but other illnesses are in full swing as well. Cases of influenza increased during holiday gatherings and travel and have been on the rise since then. In the week ...

The adjusted incident rate ratio (IRR) for GBS post-RSV disease was 2.11, reflecting a slightly more than double risk. The ...

Recent data from the Centers for Disease Control shows spikes in norovirus, Covid-19 and RSV across the U.S.—a resurgence that’s potentially unlike the usual annual winter spread of these illnesses, ...

Pfizer’s respiratory syncytial virus vaccine was more than 90% effective among older adults during the first season it was available, including among those with underlying conditions or severe disease ...

The 2025–26 respiratory syncytial virus (RSV) season is shaping up to be a pivotal moment in the fight against this significant global health threat. In just the past 2 years, three products have been ...

A wave of the highly contagious respiratory syncytial virus is beginning to wash over the United States, sending greater numbers of babies and toddlers to the hospital for professional care.

Revaccination with mRNA-1345 against RSV at 12 months was noninferior to primary vaccination among adults aged 50 years and older.